BackImunon Overview

Imunon Total Liabilities

Track Imunon's total liabilities ($4.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$4.66M
99.93% YoYΔ $-6.41B vs prior year quarter

Peer average

Loading

Imunon Total Liabilities History

Loading

Imunon vs. peers: Total Liabilities Comparison

Loading

Imunon Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Imunon (IMNN) FAQ

As of the most recent data (March 2026), IMNN shows a total liabilities of $4.7M. That compares with $6.4B in the prior-year period — down 99.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMNN's total liabilities is now $4.7M (was $6.4B) — a 99.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Imunon is outperforming or lagging.

Tracking IMNN's total liabilities over time shows whether Imunon is scaling, shrinking, or reshaping that part of the business. The current reading is $4.7M That compares with $6.4B in the prior-year period — down 99.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Imunon's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $4.7M) with ownership activity and broader fundamentals.

Imunon's total liabilities is $4.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.